Healthcare purchase

13 December 1999 00:00  [Source: ICB]

Merck-Lipha, French subsidiary of Germany's Merck, has completed its acquisition of French female healthcare specialist Théramax (ECN 29 November 1999).

By taking over Théramax, France's market leader, Merck said it will become 'a significant player' in the fast growing women's healthcare segment, which is a sector with annual sales of around $13bn.

The French group, which employs 485 people, anticipates sales of FF700m ($106.9m) in 1999. Théramax is expanding sales at 14%/year, which is in excess of market growth, said Merck. The company will retain its name, but will use its new parent's worldwide marketing network to extend its reach and to help international clinical development of new products. Merck expects synergies, especially in oncology.

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly